Scarica l'app Stockscreener
41.16
2.21%
0.89
Precedente Chiudi:
$40.27
Aprire:
$40.12
Volume 24 ore:
625.94K
Relative Volume:
0.83
Capitalizzazione di mercato:
$3.18B
Reddito:
$13.17M
Utile/perdita netta:
$-199.06M
Rapporto P/E:
-15.02
EPS:
-2.74
Flusso di cassa netto:
$-156.53M
1 W Prestazione:
+0.98%
1M Prestazione:
-4.37%
6M Prestazione:
+35.13%
1 anno Prestazione:
+3.42%
Intervallo 1D:
$39.09
$41.50
Intervallo di 1 settimana:
$39.09
$42.30
Portata 52W:
$26.74
$44.23
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
Nome
Xenon Pharmaceuticals Inc
Settore
Industria
Telefono
(604) 484-3300
Indirizzo
200 - 3650 GILMORE WAY, BURNABY
Confronta XENE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
41.16 | 3.11B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Ripresa | Wells Fargo | Overweight |
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-10-01 | Iniziato | H.C. Wainwright | Buy |
| 2024-01-04 | Iniziato | Citigroup | Buy |
| 2023-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-04-25 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-14 | Iniziato | Goldman | Buy |
| 2022-12-12 | Iniziato | Cowen | Outperform |
| 2022-11-28 | Iniziato | Wells Fargo | Overweight |
| 2022-10-19 | Iniziato | Raymond James | Outperform |
| 2022-08-29 | Iniziato | BofA Securities | Buy |
| 2022-07-21 | Iniziato | JP Morgan | Overweight |
| 2021-10-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-10-02 | Iniziato | SVB Leerink | Outperform |
| 2020-07-21 | Iniziato | Needham | Buy |
| 2020-06-01 | Ripresa | Jefferies | Buy |
| 2020-03-25 | Iniziato | Wedbush | Outperform |
| 2020-01-08 | Iniziato | William Blair | Outperform |
| 2019-09-20 | Iniziato | Guggenheim | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2017-03-13 | Iniziato | Jefferies | Buy |
| 2016-10-21 | Iniziato | Stifel | Buy |
| 2016-09-26 | Iniziato | Guggenheim | Buy |
| 2016-04-14 | Reiterato | Jefferies | Buy |
| 2015-10-30 | Ripresa | Jefferies | Buy |
| 2014-12-02 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie
Is Xenon Pharmaceuticals Inc. stock a dividend growth opportunityQuarterly Profit Report & Daily Profit Focused Screening - newser.com
Envestnet Asset Management Inc. Decreases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - Defense World
How Xenon Pharmaceuticals Inc. stock performs during Fed tightening cyclesQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Why Xenon Pharmaceuticals Inc. stock is recommended by analystsPortfolio Profit Report & Long-Term Growth Plans - newser.com
Why Xenon Pharmaceuticals Inc. stock could outperform in 2025Trend Reversal & AI Enhanced Execution Alerts - newser.com
Short interest data insights for Xenon Pharmaceuticals Inc.Weekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
Can Xenon Pharmaceuticals Inc. stock deliver sustainable ROEInsider Selling & AI Forecasted Stock Moves - newser.com
Technical signs of recovery in Xenon Pharmaceuticals Inc.Weekly Volume Report & Target Return Focused Picks - newser.com
Bank of New York Mellon Corp Raises Stock Position in Xenon Pharmaceuticals Inc. $XENE - Defense World
Xenon Pharmaceuticals (NASDAQ:XENE) Given New $60.00 Price Target at JPMorgan Chase & Co. - Defense World
Using Ichimoku Cloud for Xenon Pharmaceuticals Inc. technicalsSwing Trade & Risk Managed Investment Strategies - newser.com
How strong is Xenon Pharmaceuticals Inc. stock revenue growthWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
Will Xenon Pharmaceuticals Inc. stock continue dividend increasesQuarterly Portfolio Review & Daily Profit Focused Screening - newser.com
Chart overlay techniques for tracking Xenon Pharmaceuticals Inc.2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Why Xenon Pharmaceuticals Inc. stock is trending among retail tradersTreasury Yields & Proven Capital Preservation Tips - newser.com
When is the best time to exit Xenon Pharmaceuticals Inc.2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Meme Stocks: How Xenon Pharmaceuticals Inc. stock performs in rising dollar environmentEarnings Miss & High Yield Equity Trading Tips - Fundação Cultural do Pará
Xenon Pharmaceuticals at Stifel 2025: Strategic Expansion and Financial Stability - Investing.com Canada
What MACD and RSI say about Xenon Pharmaceuticals Inc.Weekly Earnings Recap & Daily Risk Controlled Trade Plans - newser.com
Xenon Pharmaceuticals Inc Stock Analysis and ForecastHead and Shoulders Patterns & Access Free Tools and Start Investing - earlytimes.in
What valuation multiples suggest for Xenon Pharmaceuticals Inc. stock2025 Top Decliners & Daily Entry Point Alerts - newser.com
Xenon Pharmaceuticals Inc Azioni (XENE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):